These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35119780)

  • 21. Inhibition of SARS-CoV-2 main protease: a repurposing study that targets the dimer interface of the protein.
    Pekel H; Ilter M; Sensoy O
    J Biomol Struct Dyn; 2022 Sep; 40(15):7167-7182. PubMed ID: 33847241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro.
    Ngo ST; Tam NM; Pham MQ; Nguyen TH
    J Chem Inf Model; 2021 May; 61(5):2302-2312. PubMed ID: 33829781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A computational study on active constituents of
    Shamsi S; Anjum H; Shahbaaz M; Khan MS; Ataya FS; Alamri A; Alhumaydhi FA; Husain FM; Rehman MT; Mohammad T; Islam A; Anjum F; Shamsi A
    J Biomol Struct Dyn; 2022 Oct; 40(17):7702-7713. PubMed ID: 33759703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2.
    Paul AS; Islam R; Parves MR; Mamun AA; Shahriar I; Hossain MI; Hossain MN; Ali MA; Halim MA
    J Biomol Struct Dyn; 2022 Mar; 40(4):1639-1658. PubMed ID: 33047658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism.
    Ho CY; Yu JX; Wang YC; Lin YC; Chiu YF; Gao JY; Lai SJ; Chen MJ; Huang WC; Tien N; Chen Y
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach.
    Achilonu I; Iwuchukwu EA; Achilonu OJ; Fernandes MA; Sayed Y
    J Mol Graph Model; 2020 Dec; 101():107730. PubMed ID: 32920239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV-2 Main Protease.
    Gahlawat A; Kumar N; Kumar R; Sandhu H; Singh IP; Singh S; Sjöstedt A; Garg P
    J Chem Inf Model; 2020 Dec; 60(12):5781-5793. PubMed ID: 32687345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,2,4 triazolo[1,5-a] pyrimidin-7-ones as novel SARS-CoV-2 Main protease inhibitors: In silico screening and molecular dynamics simulation of potential COVID-19 drug candidates.
    Kavitha K; Sivakumar S; Ramesh B
    Biophys Chem; 2020 Dec; 267():106478. PubMed ID: 33022567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular docking and simulation studies of natural compounds of
    Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
    J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    Life Sci; 2020 Aug; 255():117831. PubMed ID: 32450166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiazole-based SARS-CoV-2 protease (COV M
    Elsayed RW; Sabry MA; El-Subbagh HI; Bayoumi SM; El-Sayed SM
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200121. PubMed ID: 35607750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CL
    Khalifa I; Nawaz A; Sobhy R; Althwab SA; Barakat H
    J Mol Graph Model; 2020 Nov; 100():107690. PubMed ID: 32745925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Binding Pose and Affinity of Nelfinavir, a SARS-CoV-2 Main Protease Repositioned Drug, by Combining Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations.
    Handa Y; Okuwaki K; Kawashima Y; Hatada R; Mochizuki Y; Komeiji Y; Tanaka S; Furuishi T; Yonemochi E; Honma T; Fukuzawa K
    J Phys Chem B; 2024 Mar; 128(10):2249-2265. PubMed ID: 38437183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
    Ghosh A; Chakraborty M; Chandra A; Alam MP
    J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc thiotropolone combinations as inhibitors of the SARS-CoV-2 main protease.
    DeLaney C; Sheng Y; Pectol DC; Vantansever E; Zhang H; Bhuvanesh N; Salas I; Liu WR; Fierke CF; Darensbourg MY
    Dalton Trans; 2021 Sep; 50(35):12226-12233. PubMed ID: 34396374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
    Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
    Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment.
    Elzupir AO
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface.
    Liang J; Karagiannis C; Pitsillou E; Darmawan KK; Ng K; Hung A; Karagiannis TC
    Comput Biol Chem; 2020 Dec; 89():107372. PubMed ID: 32911432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the binding energetics of reversible covalent inhibitors of the SARS-CoV-2 main protease: an
    Awoonor-Williams E
    Phys Chem Chem Phys; 2022 Oct; 24(38):23391-23401. PubMed ID: 36128834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding mode characterization of 13b in the monomeric and dimeric states of SARS-CoV-2 main protease using molecular dynamics simulations.
    Kumari A; Mittal L; Srivastava M; Asthana S
    J Biomol Struct Dyn; 2022; 40(19):9287-9305. PubMed ID: 34029506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.